High density lipoprotein alterations induced by bezafibrate in healthy male volunteers

This publication has 24 references indexed in Scilit:

• Influence of bezafibrate on plasma lipoproteins, biliary lipids and fecal sterols in healthy men
  Atherosclerosis, 1986
• Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjects
  Atherosclerosis, 1985
• Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma.
  Journal of Clinical Investigation, 1983
• Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects
  Atherosclerosis, 1982
• Elevated lipoprotein lipase activity in skeletal muscle tissue during treatment of hypertriglyceridaemic patients with bezafibrate
  Atherosclerosis, 1982
• Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate
  Atherosclerosis, 1981
• Characterization of human high-density lipoproteins by gradient gel electrophoresis
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
• Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liver
  Atherosclerosis, 1978
• PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
  The Lancet, 1975
• The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV und Type V Hypertriglyceridaemia
  European Journal of Clinical Investigation, 1974